Published in Mol Cell Endocrinol on January 08, 2012
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
Protective effect of indole-3-pyruvate against ultraviolet b-induced damage to cultured HaCaT keratinocytes and the skin of hairless mice. PLoS One (2014) 1.41
RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D. FASEB J (2014) 1.39
Local melatoninergic system as the protector of skin integrity. Int J Mol Sci (2014) 1.15
Circadian clock control of endocrine factors. Nat Rev Endocrinol (2014) 1.10
The circadian clock: a framework linking metabolism, epigenetics and neuronal function. Nat Rev Neurosci (2012) 1.08
Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells. FASEB J (2013) 1.02
Novel non-calcemic secosteroids that are produced by human epidermal keratinocytes protect against solar radiation. J Steroid Biochem Mol Biol (2015) 1.00
Melatonin: an inhibitor of breast cancer. Endocr Relat Cancer (2015) 0.96
Novel vitamin D photoproducts and their precursors in the skin. Dermatoendocrinol (2013) 0.96
Melatonin and pancreatic islets: interrelationships between melatonin, insulin and glucagon. Int J Mol Sci (2013) 0.94
Fundamental issues related to the origin of melatonin and melatonin isomers during evolution: relation to their biological functions. Int J Mol Sci (2014) 0.93
Analysis of polymorphisms in the circadian-related genes and breast cancer risk in Norwegian nurses working night shifts. Breast Cancer Res (2013) 0.91
Melatonin and its metabolites ameliorate ultraviolet B-induced damage in human epidermal keratinocytes. J Pineal Res (2014) 0.90
Melatonin and its metabolites accumulate in the human epidermis in vivo and inhibit proliferation and tyrosinase activity in epidermal melanocytes in vitro. Mol Cell Endocrinol (2014) 0.90
Metabolism of melatonin in the skin: why is it important? Exp Dermatol (2016) 0.89
How to fix a broken clock. Trends Pharmacol Sci (2013) 0.88
New horizons for newborn brain protection: enhancing endogenous neuroprotection. Arch Dis Child Fetal Neonatal Ed (2015) 0.87
Immunomodulatory effects mediated by serotonin. J Immunol Res (2015) 0.85
Peripheral reproductive organ health and melatonin: ready for prime time. Int J Mol Sci (2013) 0.84
Abnormal Skeletal Growth in Adolescent Idiopathic Scoliosis Is Associated with Abnormal Quantitative Expression of Melatonin Receptor, MT2. Int J Mol Sci (2013) 0.83
Effects of melatonin on the proliferation and apoptosis of sheep granulosa cells under thermal stress. Int J Mol Sci (2014) 0.82
Obstructive sleep apnea and metabolic bone disease: insights into the relationship between bone and sleep. J Bone Miner Res (2015) 0.82
Peripheral and central effects of melatonin on blood pressure regulation. Int J Mol Sci (2014) 0.81
Human gastroenteropancreatic expression of melatonin and its receptors MT1 and MT2. PLoS One (2015) 0.81
Melatonin and the skeleton. Osteoporos Int (2013) 0.81
Skin, reactive oxygen species, and circadian clocks. Antioxid Redox Signal (2013) 0.80
Circadian clock genes and risk of fatal prostate cancer. Cancer Causes Control (2014) 0.79
Melatonin: a potential intervention for hepatic steatosis. Lipids Health Dis (2015) 0.79
Expression of the MT1 melatonin receptor in ovarian cancer cells. Int J Mol Sci (2014) 0.79
Distribution of MT1 melatonin receptor promoter-driven RFP expression in the brains of BAC C3H/HeN transgenic mice. J Histochem Cytochem (2013) 0.78
N1-Acetyl-5-Methoxykynuramine (AMK) is produced in the human epidermis and shows antiproliferative effects. Endocrinology (2015) 0.77
Mitochondria Synthesize Melatonin to Ameliorate Its Function and Improve Mice Oocyte's Quality under in Vitro Conditions. Int J Mol Sci (2016) 0.77
Oncostatic-Cytoprotective Effect of Melatonin and Other Bioactive Molecules: A Common Target in Mitochondrial Respiration. Int J Mol Sci (2016) 0.77
Synthesis and characterization of new bivalent agents as melatonin- and histamine H3-ligands. Int J Mol Sci (2014) 0.76
Neuroendocrine control of photoperiodic changes in immune function. Front Neuroendocrinol (2014) 0.76
Melatonin protects skin keratinocyte from hydrogen peroxide-mediated cell death via the SIRT1 pathway. Oncotarget (2016) 0.76
The Angiotensin-melatonin axis. Int J Hypertens (2013) 0.76
Melatonin modulates adiponectin expression on murine colitis with sleep deprivation. World J Gastroenterol (2016) 0.76
Hormonal protection in acute pancreatitis by ghrelin, leptin and melatonin. World J Gastroenterol (2014) 0.75
A Microarray-Based Analysis Reveals that a Short Photoperiod Promotes Hair Growth in the Arbas Cashmere Goat. PLoS One (2016) 0.75
Melatonin: Miracles far beyond the pineal gland. Indian J Endocrinol Metab (2012) 0.75
Synthesis and functional characterization of substituted isoquinolinones as MT2-selective melatoninergic ligands. PLoS One (2014) 0.75
Salivary Melatonin in Relation to Depressive Symptom Severity in Young Adults. PLoS One (2016) 0.75
Subcellular distribution of melatonin receptors in human parotid glands. J Anat (2013) 0.75
Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours. PLoS One (2016) 0.75
Sulfation of 6-hydroxymelatonin, N-acetylserotonin and 4-hydroxyramelteon by the human cytosolic sulfotransferases (SULTs). Xenobiotica (2015) 0.75
The Role of the Melatoninergic System in Light-Entrained Behavior of Mice. Int J Mol Sci (2017) 0.75
Integrative Therapies and Cardiovascular Disease in the Breast Cancer Population: A Review, Part 1. Integr Med (Encinitas) (2015) 0.75
Predicting cancer-relevant proteins using an improved molecular similarity ensemble approach. Oncotarget (2016) 0.75
Storage Temperature Alters the Expression of Differentiation-Related Genes in Cultured Oral Keratinocytes. PLoS One (2016) 0.75
Melatonin in the management of perinatal hypoxic-ischemic encephalopathy: light at the end of the tunnel? Neuropsychiatr Dis Treat (2016) 0.75
Melatonin and Nitrones As Potential Therapeutic Agents for Stroke. Front Aging Neurosci (2016) 0.75
Prevalence of pineal gland calcification as an incidental finding in patients referred for implant dental therapy. Imaging Sci Dent (2017) 0.75
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells. Oncotarget (2017) 0.75
Melatonin-induced KiSS1 expression inhibits triple-negative breast cancer cell invasiveness. Oncol Lett (2017) 0.75
Expression and putative functions of melatonin receptors in malignant cells and tissues. Wien Med Wochenschr (2014) 0.75
Melatonin potentiates the antitumor effect of curcumin by inhibiting IKKβ/NF-κB/COX-2 signaling pathway. Int J Oncol (2017) 0.75
Associations of melatonin receptor gene polymorphisms with Graves' disease. PLoS One (2017) 0.75
Ameliorative effects of melatonin administration and photoperiods on diurnal fluctuations in cloacal temperature of Marshall broiler chickens during the hot dry season. Int J Biometeorol (2014) 0.75
Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev (2004) 5.89
Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal (2009) 3.19
Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res (2004) 2.87
One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res (2007) 2.84
Aromatic L-amino acid decarboxylase. J Biol Chem (1962) 2.70
Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev (1991) 2.69
Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol (2008) 2.47
Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res (2011) 2.12
Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron (1994) 1.95
Melatonin, endocrine pancreas and diabetes. J Pineal Res (2008) 1.94
Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci U S A (1995) 1.94
Crystal structure of the human RORalpha Ligand binding domain in complex with cholesterol sulfate at 2.2 A. J Biol Chem (2004) 1.87
Functional MT1 and MT2 melatonin receptors in mammals. Endocrine (2005) 1.87
Evidence for a circadian rhythm of insulin secretion. Am J Physiol (1996) 1.86
Hair follicle pigmentation. J Invest Dermatol (2005) 1.84
RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol Endocrinol (1994) 1.81
The melatonin rhythm: both a clock and a calendar. Experientia (1993) 1.79
Heptahelical receptor signaling: beyond the G protein paradigm. J Cell Biol (1999) 1.78
The cutaneous serotoninergic/melatoninergic system: securing a place under the sun. FASEB J (2005) 1.77
Function and expression of melatonin receptors on human pancreatic islets. J Pineal Res (2008) 1.75
Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J Biol Chem (2002) 1.68
Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci (2002) 1.67
Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians. Diabetes (2009) 1.65
The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization. EMBO J (2006) 1.64
Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem (2000) 1.59
A review of the multiple actions of melatonin on the immune system. Endocrine (2005) 1.55
Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J Neuroimmunol (1986) 1.51
Tryptophan hydroxylation: measurement in pineal gland, brainstem, and carcinoid tumor. Science (1967) 1.49
Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial. Br J Dermatol (2004) 1.49
Melatonin. BMJ (1996) 1.46
Melatonin: a multitasking molecule. Prog Brain Res (2010) 1.46
Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands. J Biol Chem (1960) 1.45
International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev (2010) 1.45
On the role of melatonin in skin physiology and pathology. Endocrine (2005) 1.43
Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? Br J Pharmacol (2008) 1.42
Melatonin: the chemical expression of darkness. Mol Cell Endocrinol (1991) 1.41
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39
Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers. Mol Pharmacol (2004) 1.37
The metabolism of serotonin (5-hydroxytryptamine). J Biol Chem (1959) 1.36
Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci (2003) 1.32
Significance of melatonin in antioxidative defense system: reactions and products. Biol Signals Recept (2000) 1.31
A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res (2011) 1.30
Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril (2008) 1.29
Non-vertebrate melatonin. J Pineal Res (2003) 1.28
Cancer in rodents: does it tell us about cancer in humans? Nat Rev Cancer (2005) 1.27
Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J (1998) 1.26
Metabolism of melatonin by human cytochromes p450. Drug Metab Dispos (2004) 1.26
A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res (2006) 1.25
Melatonin promotes osteoblast differentiation and bone formation. J Biol Chem (1999) 1.23
Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res (2003) 1.23
Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci U S A (1994) 1.23
In vitro and in vivo formation of two new metabolites of melatonin. J Biol Chem (1974) 1.22
Role of pineal gland in aetiology and treatment of breast cancer. Lancet (1978) 1.21
Experimental hypertension in pinealectomized rats. Life Sci (1967) 1.21
Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci (1995) 1.21
Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci (2007) 1.20
The human oocyte and cumulus cells relationship: new insights from the cumulus cell transcriptome. Mol Hum Reprod (2010) 1.20
Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab (2007) 1.20
Molecular tools to study melatonin pathways and actions. Trends Pharmacol Sci (2005) 1.18
Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science (1994) 1.17
Melatonin and pregnancy in the human. Reprod Toxicol (2008) 1.17
Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J Immunol (1997) 1.16
Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol (1998) 1.15
Melatonin increases oestrogen receptor binding activity of human breast cancer cells. Nature (1983) 1.11
The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev (1993) 1.10
Role of subunit diversity in signaling by heterotrimeric G proteins. Biochem Pharmacol (1997) 1.10
Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem (1994) 1.10
Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev (2011) 1.10
Melatonin effects on bone: experimental facts and clinical perspectives. J Pineal Res (2003) 1.10
Cardiovascular diseases: protective effects of melatonin. J Pineal Res (2008) 1.10
Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions. Cancer Detect Prev (2006) 1.10
Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins. Mol Endocrinol (1999) 1.09
Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. J Bone Miner Res (2002) 1.09
Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction. Am J Physiol Renal Physiol (2007) 1.08
Cloning of a melatonin-related receptor from human pituitary. FEBS Lett (1996) 1.07
Role of melatonin in upper gastrointestinal tract. J Physiol Pharmacol (2007) 1.07
Melatonin. Clin Endocrinol (Oxf) (1988) 1.07
Thirty four years since the discovery of gastrointestinal melatonin. J Physiol Pharmacol (2008) 1.07
Role of cyclic AMP in mediating the effects of MSH, norepinephrine, and melatonin on frog skin color. Endocrinology (1969) 1.06
Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol Sci (1996) 1.06
Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab (1987) 1.05
Circadian and seasonal variation in human preovulatory follicular fluid melatonin concentration. J Clin Endocrinol Metab (1990) 1.05
Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res (2010) 1.04
A role of melatonin in neuroectodermal-mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors. FASEB J (2005) 1.03
N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J (2001) 1.03
Role of melatonin in metabolic regulation. Rev Endocr Metab Disord (2009) 1.03
Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway. Breast Cancer Res (2010) 1.03
Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair. Exp Dermatol (2008) 1.03
Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res (2010) 1.02
Direct action of melatonin in human granulosa-luteal cells. J Clin Endocrinol Metab (2001) 1.02
Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int J Oncol (2006) 1.02
Melatonin and serotonin effects on gastrointestinal motility. J Physiol Pharmacol (2007) 1.02
Evidence for the expression of both the MT1- and in addition, the MT2-melatonin receptor, in the rat pancreas, islet and beta-cell. J Pineal Res (2007) 1.02
Expression of melatonin receptors in arteries involved in thermoregulation. Proc Natl Acad Sci U S A (1990) 1.01
Involvement of the mt1 melatonin receptor in human breast cancer. Cancer Lett (2002) 1.01
Pinealectomy causes glucose intolerance and decreases adipose cell responsiveness to insulin in rats. Am J Physiol (1998) 1.00
Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 . Biochem Pharmacol (2001) 1.00
Identification of natural ligands of retinoic acid receptor-related orphan receptor alpha ligand-binding domain expressed in Sf9 cells--a mass spectrometry approach. Anal Biochem (2003) 1.00
Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp Cell Res (1993) 0.99
Structure, characterization, and expression of the gene encoding the mouse Mel1a melatonin receptor. Endocrinology (1996) 0.99
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res (2004) 2.87
One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res (2007) 2.84
Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res (2011) 2.12
Melatonin: from basic research to cancer treatment clinics. J Clin Oncol (2002) 1.99
20-Hydroxyvitamin D3, a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates keratinocyte differentiation. J Invest Dermatol (2008) 1.91
Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem (2002) 1.75
Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling. Cell Mol Neurobiol (2003) 1.69
20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes. PLoS One (2009) 1.65
On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res (2012) 1.60
A review of the multiple actions of melatonin on the immune system. Endocrine (2005) 1.55
Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. Neurobiol Dis (2005) 1.52
Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma. Hum Pathol (2013) 1.50
Caveolae and lipid rafts: G protein-coupled receptor signaling microdomains in cardiac myocytes. Ann N Y Acad Sci (2005) 1.48
cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts. Am J Physiol Cell Physiol (2004) 1.47
20,23-dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF-kappaB activity in human keratinocytes. J Cell Physiol (2010) 1.44
Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res (2008) 1.40
Expression of vitamin D receptor decreases during progression of pigmented skin lesions. Hum Pathol (2011) 1.38
cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts. Mol Pharmacol (2006) 1.34
Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy. Int J Cancer (2008) 1.33
Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci (2014) 1.31
Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation. J Biol Chem (2002) 1.30
Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res (2009) 1.29
Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril (2008) 1.29
Melatonin mitigates mitochondrial malfunction. J Pineal Res (2005) 1.27
Causes of oxidative stress in the pre- and perinatal period. Biol Neonate (2002) 1.26
Melatonin as a radioprotective agent: a review. Int J Radiat Oncol Biol Phys (2004) 1.25
Photo-conversion of two epimers (20R and 20S) of pregna-5,7-diene-3beta, 17alpha, 20-triol and their bioactivity in melanoma cells. Steroids (2008) 1.24
Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res (2003) 1.23
Melatonin-immune system relationships. Curr Top Med Chem (2002) 1.21
A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J Pineal Res (2012) 1.21
Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res (2008) 1.21
Cytochromes p450 and skin cancer: role of local endocrine pathways. Anticancer Agents Med Chem (2014) 1.20
Melatonin and mitochondrial function. Life Sci (2004) 1.20
Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review. J Pineal Res (2014) 1.20
Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. J Pineal Res (2011) 1.20
Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. J Pineal Res (2011) 1.19
Functional roles of melatonin in plants, and perspectives in nutritional and agricultural science. J Exp Bot (2011) 1.19
Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res (2011) 1.18
Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J (2004) 1.17
Melatonin and pregnancy in the human. Reprod Toxicol (2008) 1.17
Defining chronodisruption. J Pineal Res (2009) 1.17
Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin's primary function and evolution in eukaryotes. J Pineal Res (2012) 1.15
Corticotropin-releasing hormone induces keratinocyte differentiation in the adult human epidermis. J Cell Physiol (2005) 1.14
Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol (2005) 1.14
Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats. J Pineal Res (2007) 1.11
Corticotropin-releasing hormone stimulates NF-kappaB in human epidermal keratinocytes. J Endocrinol (2004) 1.10
Cardiovascular diseases: protective effects of melatonin. J Pineal Res (2008) 1.10
Shift work and cancer: the evidence and the challenge. Dtsch Arztebl Int (2010) 1.10
Expression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression. Hum Pathol (2012) 1.09
Phytomelatonin: a review. J Exp Bot (2008) 1.09
Synthesis and photo-conversion of androsta- and pregna-5,7-dienes to vitamin D3-like derivatives. Photochem Photobiol Sci (2008) 1.09
Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism. Prostate (2005) 1.08
Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard. Toxicol Lett (2007) 1.08
Chronodisruption and cancer. Naturwissenschaften (2008) 1.08
Vitamin D analogs 17,20S(OH)2pD and 17,20R(OH)2pD are noncalcemic and exhibit antifibrotic activity. J Invest Dermatol (2011) 1.08
Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J Pineal Res (2007) 1.07
Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1. FASEB J (2003) 1.07
The RNA-seq approach to discriminate gene expression profiles in response to melatonin on cucumber lateral root formation. J Pineal Res (2013) 1.07
Mechanisms of cancer inhibition by melatonin. J Pineal Res (2004) 1.06
Melatonin-mitochondria interplay in health and disease. Curr Top Med Chem (2011) 1.06
Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. J Pineal Res (2005) 1.06
Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J Pineal Res (2004) 1.05
Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. J Pineal Res (2008) 1.05
Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res (2010) 1.04
Melatonin as an antioxidant: physiology versus pharmacology. J Pineal Res (2005) 1.03
Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med (2008) 1.03
The role of melanin pigment in melanoma. Exp Dermatol (2015) 1.03
Role of melatonin in metabolic regulation. Rev Endocr Metab Disord (2009) 1.03
Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair. Exp Dermatol (2008) 1.03
Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res (2010) 1.02
Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells. FASEB J (2013) 1.02
Melatonin and circadian biology in human cardiovascular disease. J Pineal Res (2010) 1.01
Synthesis and photochemical transformation of 3β,21-dihydroxypregna-5,7-dien-20-one to novel secosteroids that show anti-melanoma activity. Steroids (2010) 1.01
The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors. J Pineal Res (2010) 1.01
Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review. Expert Opin Ther Targets (2013) 1.00
A generalized theory of carcinogenesis due to chronodisruption. Neuro Endocrinol Lett (2008) 1.00
CRF1 receptor splicing in epidermal keratinocytes: potential biological role and environmental regulations. J Cell Physiol (2009) 1.00
Stress response and procedural pain in the preterm newborn: the role of pharmacological and non-pharmacological treatments. Eur J Pediatr (2011) 1.00
Prophylactic effect of melatonin in reducing lead-induced neurotoxicity in the rat. Cell Mol Biol Lett (2003) 0.99
Light, timing of biological rhythms, and chronodisruption in man. Naturwissenschaften (2003) 0.99
Correlation between secosteroid-induced vitamin D receptor activity in melanoma cells and computer-modeled receptor binding strength. Mol Cell Endocrinol (2012) 0.99
The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness. Biol Rev Camb Philos Soc (2009) 0.99
Expression of molecular equivalent of hypothalamic-pituitary-adrenal axis in adult retinal pigment epithelium. J Endocrinol (2007) 0.98
Genetic variation of the cutaneous HPA axis: an analysis of UVB-induced differential responses. Gene (2013) 0.98
Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rep (2003) 0.98
Melatonin and tryptophan affect the activity-rest rhythm, core and peripheral temperatures, and interleukin levels in the ringdove: changes with age. J Gerontol A Biol Sci Med Sci (2009) 0.98
Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. Am J Perinatol (2004) 0.98
AMPK involvement in endoplasmic reticulum stress and autophagy modulation after fatty liver graft preservation: a role for melatonin and trimetazidine cocktail. J Pineal Res (2013) 0.98
Structure-activity relationship studies of arylthiazolidine amides as selective cytotoxic agents for melanoma. Anticancer Res (2007) 0.97
Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells. J Pineal Res (2010) 0.97
Pain in neonatal intensive care: role of melatonin as an analgesic antioxidant. J Pineal Res (2011) 0.97
Melatonin: potential functions in the oral cavity. J Periodontol (2007) 0.97
Emerging role of alternative splicing of CRF1 receptor in CRF signaling. Acta Biochim Pol (2010) 0.97
Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice. J Pineal Res (2006) 0.97
Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J Pineal Res (2009) 0.96
Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection. J Pineal Res (2007) 0.96
Melatonin protects against isoproterenol-induced myocardial injury in the rat: antioxidative mechanisms. J Pineal Res (2010) 0.96
Exogenously applied melatonin stimulates root growth and raises endogenous indoleacetic acid in roots of etiolated seedlings of Brassica juncea. J Plant Physiol (2008) 0.96